GABAB Receptor Antibody Testing for Autoimmune Encephalitis Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing autoimmune encephalitis and epilepsy are inadequate, as they lack specificity and sensitivity, particularly in identifying the underlying cause, such as tumors associated with these conditions, which can lead to delayed or inappropriate treatment.
Innovation Solution
A method involving the testing of biological samples for the presence of antibodies to the GABA B receptor, specifically the B1 and B2 subunits, to diagnose autoimmune encephalitis, occult tumors causing encephalitis, or tumors causing epilepsy, using cerebrospinal fluid, serum, or plasma samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional diagnostic methods are used for autoimmune encephalitis and epilepsy, then the diagnostic process is simpler and less costly, but the diagnosis lacks specificity and sensitivity, leading to delayed or inappropriate treatment
Solution Approach 1:
The diagnostic approach is segmented into multiple specific antibody tests targeting different neuronal antigens (NMDAR, AMPAR, GABA A, GABA B, VGKC, GAD65). This segmentation allows for precise identification of specific autoimmune encephalitis subtypes, improving diagnostic accuracy while maintaining a systematic and organized diagnostic workflow that manages complexity through structured testing protocols
2Reliability
If conventional diagnostic methods are used, then the diagnostic workflow is faster and less resource-intensive, but the ability to identify underlying tumors is reduced
Solution Approach 1:
The patent implements preliminary comprehensive antibody screening across multiple neuronal antigen targets before finalizing the diagnosis. This preliminary action ensures that potential tumor-associated antibodies are detected early in the diagnostic process, allowing for timely tumor identification and intervention while establishing a thorough diagnostic foundation that prevents missed diagnoses
Solution Approach 2:
The diagnostic process incorporates feedback loops where antibody test results guide further investigative actions. Positive antibody findings trigger targeted tumor screening and imaging, while negative results guide alternative diagnostic pathways. This feedback mechanism optimizes the balance between thoroughness and efficiency, ensuring tumor identification without unnecessary delays
3Measurement precision
If comprehensive antibody testing is performed, then the diagnostic specificity and tumor detection improve, but the complexity and cost of the diagnostic process increase
Solution Approach 1:
The patent employs a universal diagnostic panel that tests for multiple neuronal antibody targets simultaneously using standardized assay methodologies. This multi-functional approach allows a single diagnostic workflow to address various autoimmune encephalitis subtypes and potential paraneoplastic syndromes, improving disease subtype identification accuracy while maintaining implementation ease through standardized protocols that can be performed in常规 clinical laboratories
Data Source
Figure 1a~1d
Figure 2a~2d
Figure 3a~3c
AI summary
This invention provides methods of diagnosing or determining a cause of an autoimmune encephalitis or an epilepsy in a subject and of diagnosing a tumor in a subject, comprising the step of testing a biological sample of the subject for an antibody to a GABAB receptor. This invention further provides methods of treating an autoimmune encephalitis or an epilepsy, comprising the steps of detecting an antibody to a GABAB receptor and treating a tumor associated with the disease.